All Studies

Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19.

The combination of traditional Chinese medicine and western medication appears to be an effective treatment strategy for COVID-19 patients in China. This review focuses on the relationship between COVID-19 and gut microbiota and the potential impact of traditional Chinese medicine on gut microbiota in treating COVID-19 patients. Available data suggests that gut microbiota dysbiosis occurs in COVID-19 patients, and intervention can improve patient's clinical condition. Certain traditional Chinese medicines have been proven to be safe and effective for treating COVID-19, and they have a positive impact on gut microbiota, immunity, and angiotensin converting enzyme 2. The hypothesis of gut microbiota-mediated traditional Chinese medicine treatment of COVID-19 is proposed, but more clinical trials and basic experiments are needed to confirm this hypothesis.

Zhang Q et al (2021).
Am J Chin Med.
PubMed:
33853498

CD24 gene inhibition and TIMP-4 gene upregulation by Imperata cylindrica's root extract prevents metastasis of CaSki cells via inhibiting PI3K/Akt/snail signaling pathway and blocking EMT.

Nayim P et al (2021).
J Ethnopharmacol.
PubMed:
33848610

Genome-wide quantitative trait loci mapping on Verticillium wilt resistance in 300 chromosome segment substitution lines from Gossypium hirsutum × Gossypium barbadense.

Scientists conducted a study to identify genetic regions associated with resistance to Cotton Verticillium wilt (VW). They identified 40 relevant regions and 70 novel hotspot regions, which can be used in breeding programs to develop resistant cotton varieties.

Rashid MHO et al (2021).
G3 (Bethesda).
PubMed:
33846710